ENT Devices Market Size
|2019 - 2029
|Base Year For Estimation
|Fastest Growing Market
*Disclaimer: Major Players sorted in no particular order
Need a report that reflects how COVID-19 has impacted this market and its growth?
ENT Devices Market Analysis
The ENT Devices Market is projected to register a CAGR of 6.4% during the forecast period, 2022-2027.
The Pandemic has had ramifications for ways of working, of various ear, nose, throat (ENT) surgical and diagnostics procedures including minimally invasive procedures. According to the study titled "ENT Symptomology in Active COVID-19 Patients in our Tertiary Care Centre" published in August 2021, Anosmia and dysgeusia are significantly linked to COVID-19 disease, the nasal cavity has a higher viral concentration than the throat. Additionally, paucisymptomatic and asymptomatic COVID-19-positive patients have reported anosmia and dysgeusia. Thus, the rise in ENT infection in COVID-19 patient drive the demand for ENT devices. Moreover, due to the lockdown, a delay in diagnosis and treatments are being observed in patients with ENT diseases because of a reduction in hospital visits, and also many hospitals are trying to conserve the resources in treating COVID-19 patients who are declining the diagnosis of ENT diseases. THowever, with the ongoing vaccinations and decreasing COVID-19 cases, the ENT devices market is expected to regain its full potential over the forecast period.
The major factors for the growth of the ENT devices market include the increasing prevalence of ear, nose, and throat-related disorders, rising adoption of minimally invasive ENT procedures, and technological advancements. Sinusitis is one of the medical conditions wherein the cavities around the nasal passages (sinuses) are inflamed or swollen for more than twelve weeks. According to the study titled " Odontogenic Sinusitis: From Diagnosis to Treatment Possibilities-A Narrative Review of Recent Data" published in the MDPI Diagnosis, In Jun 2022, in the United States, sinusitis costs about USD 6 billion annually, plus USD 2 billion for over-the-counter remedies, with a prevalence rate of 10.4% in Europe and 14.0% in the United States. Also, more than 0.5 million surgeries for the treatment of chronic sinusitis are performed in the United States every year.
Also, according to the Action on Hearing Loss Information in April 2022, one out of every six people or over 10 million people in the United Kingdom suffer from hearing loss. Out of these, 6.4 million people belonged to the age group of 65 and above and 800,000 people suffered from severe or profound deafness. As the prevalence of hearing loss increased in the country the demand for the ENT devices is expected to increase over the forecast period, thereby boosting the market growth. Furthermore, according to the data published by the American Cancer Society April 2021, about 2,000 people in the United States develop cancers of the nasal cavity and paranasal sinuses each year. These cases are most common in the geriatric population. Thus, owing to the rising prevalence and new cases of ear, nose, and throat related disorders, the ENT devices market is expected to witness a high growth over the forecast period. However, high procedures and treatment cost and social stigma restrain the market growth over the forecast period.
ENT Devices Market Trends
This section covers the major market trends shaping the ENT Devices Market according to our research experts:
Hearing Aids Segment is Expected to Account for Fastest Growth Rate during the Forecast Period
A hearing aid is a small electronic device that you wear in or behind your ear. It makes some sounds louder so that a person with hearing loss can listen, communicate, and participate more fully in daily activities. A hearing aid can help people hear more in both quiet and noisy situations. Hearing aids are primarily useful in improving the hearing and speech comprehension of people who have hearing loss that results from damage to the small sensory cells in the inner ear.
Moreover, the demand for these devices is increasing due to the increasing population with hearing loss. As per an April 2021 report by the World Health Organization, At least 700 million people will need hearing rehabilitation by 2050, when it is predicted that nearly 2.5 billion people will have some degree of hearing loss. Due to unsafe listening habits, over 1 billion young adults are at risk of developing permanent, preventable hearing loss. Moreover, with the increasing technological advancements, hearing aids are expected to witness high demand. Widex was awarded at the CES 2019 Best of Innovation Awards ceremony for WIDEX EVOKETM, which features WIDEX ENERGY CELL technology in the fitness, sports, and biotech product categories. It is a battery-free hearing aid. This will increase the demand for hearing aids, which will boost the market growth.
However, growing product launches by the key market players are anticipated to boost the market growth. For instance, in February 2022, Oticon, Inc. expanded its hearing aid portfolio to allow even more individuals with hearing loss to experience the benefits of Oticon's advanced BrainHearing technology. The additions include two new Oticon More miniBTE styles that meet the needs of users who prefer small, discreet, behind-the-ear (BTE) options, as well as two new hearing aid families. Similarly, in October 2021, morning health tech company Audibel reported launching its new artificial intelligence hearing aids called the Arc AI. Thus, all aforementioned factors are expected to boost the segment growth over the forest period.
North America Accounted for the Largest Share in the Global Market
North America is expected to hold a major share of the ENT devices market and is expected to show a similar trend over the forecast period, without significant fluctuations. Most of the market players are based in North America and there is awareness about the advantages of using ENT device solutions with the high burden of the END disorders in the region which are expected to be major driving factors for the studied market in the region. For instance, according to March 2021 report of the National Institute of Deafness and Other Communication Disorders of the United States1, as per common hearing tests, one in eight Americans (13 percent, or 30 million) who are 12 years of age or older have hearing loss in both ears. The prevalence of hearing loss in adults between the ages of 45 and 54 is around 2%. For adults aged 55 to 64, the rate rises to 8.5%. Moreover, with the increasing aging population, there has been a rising prevalence of hearing loss and laryngeal cancer, and other ENT disorders.
As per the American Cancer Society 2022 report, about 12,470 new cases of laryngeal cancer are expected to be recorded in the United States in 2022. Thus, the high burden of ENT disorders coupled with favorable reimbursement policies, and better healthcare infrastructure is the reasons for the high market share of North America. Further, increasing product launches by the key market players boost the market growth. For Instance, in January 2021, Oticon, Inc. launched Oticon More, one of the first hearing aid built with an onboard deep neural network (DNN), indicated for people with mild-to-severe hearing loss. Similarly, in August 2020, GN Hearing launched the ReSound ONE, one of the revolutionary new hearing aid that solves one of the most enduring challenges for people with hearing loss. Thus, all aforementioned factors are expected to boost the market growth over the forest period.
ENT Devices Industry Overview
The market studied is consolidated owing to the presence of a few major players in the market. The market players are focusing on R&D to develop the technologically advanced products in order to bring innovative products in the market. The barriers for the new entrants are high in this industry and hence only a few major market players hold the maximum market share. some of the players are American Hearing Systems Inc., Atos Medical, Cochlear Ltd, InHealth Technologies, Medtronic PLC
ENT Devices Market Leaders
Sivantos Group (Signia)
*Disclaimer: Major Players sorted in no particular order
ENT Devices Market News
- In February 2022, Medtronic launched its NuVent Eustachian tube dilation balloon, which gives surgeons an outpatient option for some ear, nose, and throat conditions.
- In January 2022, Acclarent Inc., part of the Johnson & Johnson Medical Devices Companies launched its first-ever AI-powered ENT technology, designed to simplify surgical planning and provide real-time feedback during ENT navigation procedures.
ENT Devices Market Report - Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Ear, Nose, and Throat Related Disorders
4.2.2 Rising Adoption of Minimally Invasive ENT Procedures
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 High Procedure and Instruments Cost
4.3.2 Social Stigma
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Product
5.1.1 Diagnostic Devices
5.1.2 Surgical Devices
5.1.3 Hearing Aids
5.1.4 Image-guided Surgery Systems
5.1.5 Other Products
5.2 By End User
5.2.2 ENT Clinics
5.2.3 Other End Users
5.3.1 North America
18.104.22.168 United States
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
5.3.4 Middle East and Africa
220.127.116.11 South Africa
18.104.22.168 Rest of Middle East and Africa
5.3.5 South America
22.214.171.124 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 American Hearing Systems Inc.
6.1.2 Atos Medical
6.1.3 Cochlear Ltd
6.1.4 Fujifilm Corporation
6.1.5 InHealth Technologies
6.1.6 Medtronic PLC
6.1.7 Nurotron Biotechnology Co. Ltd
6.1.8 Olympus Corporation
6.1.9 Richard Wolf GmbH
6.1.10 Sivantos Group (Signia)
6.1.11 Starkey Laboratories Inc.
6.1.12 Stryker Corporation
6.1.13 Welch Allyn
6.1.14 Zhejiang Shendasiao Medical Instrument Co.,Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
ENT Devices Market Research FAQs
What is the current Global ENT Devices Market size?
The Global ENT Devices Market is projected to register a CAGR of 6.40% during the forecast period (2024-2029)
Who are the key players in Global ENT Devices Market?
Cochlear Ltd, Medtronic PLC, Olympus Corporation, Stryker Corporation and Sivantos Group (Signia) are the major companies operating in the Global ENT Devices Market.
Which is the fastest growing region in Global ENT Devices Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global ENT Devices Market?
In 2024, the North America accounts for the largest market share in Global ENT Devices Market.
What years does this Global ENT Devices Market cover?
The report covers the Global ENT Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global ENT Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
ENT Devices Industry Report
Statistics for the 2024 ENT Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. ENT Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.